Literature DB >> 32082839

A case of surgically treated bilateral metachronous malignant pleural mesothelioma.

Mehmet Ali Bedirhan1, Levent Cansever1, Adnan Yöney2, Celalettin Kocatürk1.   

Abstract

In this article, we present a 59-year-old male patient who was admitted to our hospital with right pleural effusion and right-sided chest pain and diagnosed as malignant pleural mesothelioma with thoracentesis and pleural biopsy. After the patient was determined to be operable, right parietal pleurectomy + pericardial resection + diaphragmatic resection were performed and four cycles of cisplatin and pemetrexed combination as adjuvant treatment were added. The patient was followed-up without any problem for three and a half years. At this time, left-sided chest pain and leftsided effusion were noticed. Tumor was negative in thoracentesis and pleural biopsy. Then, video-assisted thoracoscopic surgery was applied, which resulted in Stage 1a malignant pleural mesothelioma. Thoracoscopic parietal pleurectomy was performed with success. Four cycles of pemetrexed single-agent therapy was performed as an adjuvant treatment. The patient died of chronic obstructive pulmonary disease and heart failure in 57th month of the first and 21st month of the second operation while he was tumor free. To the best of our knowledge, this case is the first operated bilateral metachronous primary malignant pleural mesothelioma in the literature.
Copyright © 2019, Turkish League Against Rheumatism.

Entities:  

Keywords:  Asbestosis; malign pleural mesothelioma; pleural tumor; surgery

Year:  2019        PMID: 32082839      PMCID: PMC7021381          DOI: 10.5606/tgkdc.dergisi.2019.16162

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  8 in total

1.  Cyberknife radiosurgery for focal paravertebral recurrence after radical pleurectomy/decortication in malignant pleural mesothelioma.

Authors:  Loïc Lang-Lazdunski; Sally Barrington; Andrea Bille; Pierre-Yves Bondiau
Journal:  Eur J Cardiothorac Surg       Date:  2012-01-18       Impact factor: 4.191

Review 2.  Management of recurrence after initial surgery for malignant pleural mesothelioma: a mini-review.

Authors:  Semih Halezeroğlu; Marcello Migliore
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

3.  Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy?

Authors:  Mehmet Ali Bedirhan; Levent Cansever; Adalet Demir; Süleyman Ceyhan; Hasan Akın; Halide Nur Urer; Aysun Olçmen; Celalettin Kocatürk; Ibrahim Dinçer
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

4.  Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy.

Authors:  Leonardo Politi; Giuseppe Borzellino
Journal:  Ann Thorac Surg       Date:  2010-01       Impact factor: 4.330

Review 5.  [Bilateral malignant mesothelioma of the tunica vaginalis testis. Apropos of a case].

Authors:  P Menut; J M Hervé; M Barbagelata; H Botto
Journal:  Prog Urol       Date:  1996 Aug-Sep       Impact factor: 0.915

6.  Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma.

Authors:  Hasan Fevzi Batirel; Muzaffer Metintas; Hale Basak Caglar; Guntulu Ak; Perran Fulden Yumuk; Rengin Ahiskali; Emine Bozkurtlar; Nural Bekiroglu; Tunc Lacin; Bedrettin Yildizeli; Mustafa Yuksel
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-09       Impact factor: 5.209

Review 7.  Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature.

Authors:  Alessandro Del Gobbo; Stefano Fiori; Gabriella Gaudioso; Eleonora Bonaparte; Silvia Tabano; Alessandro Palleschi; Silvano Bosari; Stefano Ferrero
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Malignant mesothelioma of the pleura and other malignancies in the same patient.

Authors:  Claudio Bianchi; Tommaso Bianchi; Lucia Ramani
Journal:  Tumori       Date:  2007 Jan-Feb
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.